Aspen Waite Group News Summer 2021

Page 20

06 20

Covid-19 Vaccination Rollout: UK Progress and International Outlook Dr. Oksana Artyomenko MD FRSM

With Covid restrictions now being gradually eased, we all feel like there is finally a light at the end of the tunnel. It is fair to say that the UK vaccine rollout is already an outstanding achievement, which puts us far ahead of many countries in terms of number of people vaccinated. As of May 7th, 76.7 vaccine doses per 100 people have been given in the UK, with a total of over 51.2 million doses. And there are already promising signs the vaccines are reducing hospital admissions and deaths, as well as community transmission. Of note, an Oxford-AstraZeneca vaccine remains the most widely used in the world (Figure 1). It therefore has the most real-world data collected from its use, giving additional confidence in its safety and effectiveness profile.

Oksana.Artyomenko@aspen-waite.co.uk

Oxford-AstraZeneca

141

Pfizer-BioNTech

87

Sinopharm

40

Moderna

38

Sputnik V

32

Sinovac

23

Janssen

14

CanSino

2

EpiVacCorona

1

Covaxin (Bharat Biotech)

1 0

50

100

Figure 1: Only includes locations where data on doses administered is available Source: Our World in Data, 11.30 BST on 7 May


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
Aspen Waite Group News Summer 2021 by Aspen Waite - Issuu